Our transcriptomic analyses of Mamu-B*08+ RMs, both vaccinated and unvaccinated, and Mamu-B*08– RMs during the first two weeks of SIVmac239 infection suggest that numerous innate immune factors, as well as the intensity and duration of pro-inflammatory innate immune responses, differentiate ECs from CPs. This evidence concerns the gene CAD and infection.